医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
3-苄基腺嘌呤 | 3-benzyladenine | 7280-81-1 | C12H11N5 |
|
3-苄基噻吩 | 3-benzylthiophene | 27921-48-8 | C11H10S |
|
3-苄基吡啶 | 3-benzylpyridine | 620-95-1 | C12H11N |
|
3-苄基-8-(叔丁氧基羰基)-3,8-二氮杂双环[3.2.1]-辛烷 | tert-butyl 3-benzyl-3,8-diazabicyclo[3.2.1]octane-8-carboxylate | 149771-43-7 | C18H26N2O2 |
|
3-苄基-6-溴-2-甲氧基喹啉 | 3-benzyl-6-bromo-2-methoxyquinoline | 654655-69-3 | C17H14BrNO |
|
3-苄基-6-溴-2-氯喹啉 | 3-benzyl-6-bromo-2-chloroquinoline | 654655-68-2 | C16H11BrClN |
|
3-胺基-2,5-二溴吡啶 | 2,5-dibromopyridin-3-amine | 90902-84-4 | C5H4Br2N2 |
|
3-肼基哒嗪盐酸盐 | 3-hydrazinylpyridazine | 40972-16-5 | C4H6N4 |
|
3-肼基吡啶盐酸盐 | 3-Hydrazinylpyridine dihydrochloride | 364727-74-2 | C5H9Cl2N3 |
|
3-肼基吡啶 | 3-hydrazinopyridine | 42166-50-7 | C5H7N3 |
|
3-肼基-6-苯基吡嗪 | 3-hydrazino-6-phenylpyridazine | 38956-80-8 | C10H10N4 |
|
3-肼基-6-甲基哒嗪 | 3-hydrazinyl-6-methylpyridazine | 38956-79-5 | C5H8N4 |
|
3-肼基-4-氨基-6-氯哒嗪 | 6-chloro-3-hydrazinylpyridazin-4-amine | 934-26-9 | C4H6ClN5 |
|
3-羰基-1-茚酸 | 3-oxoindan-1-carboxylic acid | 29427-69-8 | C10H8O3 |
|
3-羧酸-4-羧酸甲酯吡啶 | 4-(methoxycarbonyl)nicotinic acid | 24202-74-2 | C8H7NO4 |
|
3-羧甲基绕丹宁 | rhodanine 3-acetic acid | 5718-83-2 | C5H5NO3S2 |
|
3-羧基哒嗪 | pyridazine-3-carboxylic acid | 2164-61-6 | C5H4N2O2 |
|
3-羟甲基苯并噻吩 | benzo[b]thiophen-3-yl methanol | 5381-24-8 | C9H8OS |
|
3-羟甲基-4-甲基吡啶 | (4-methylpyridin-3-yl)methanol | 4664-27-1 | C7H9NO |
|
3-羟甲基-4-溴安替比林 | 3-hydroxymethyl-4-bromoantipyrine | 81122-69-2 | C11H11BrN2O2 |
|
3-羟甲基-2-甲基吡啶 | (2-methylpyridin-3-yl)methanol | 56826-61-0 | C7H9NO |
|
3-羟甲基-1H-喹啉-2-酮 | 3-(hydroxymethyl)-(1H)-quinol-2-one | 90097-45-3 | C10H9NO2 |
|
3-羟基苯并噻吩 | 3-hydroxybenzothiophene | 520-72-9 | C8H6OS |
|
3-羟基苯乙酸 | 3-hydroxyphenylacetic acid | 621-37-4 | C8H8O3 |
|
3-羟基甲基吲哚-1-羧酸叔丁酯 | t-butyl 3-hydroxymethylindole-1-carboxylate | 96551-22-3 | C14H17NO3 |
|
3-羟基氮杂环丁烷盐酸盐 | azetion-3-ol hydrochloride | 18621-18-6 | C3H7NO*ClH |
|
3-羟基异苯并呋喃-1(3H)-酮 | 3-hydroxy-1(3H)-isobenzofuranone | 16859-59-9 | C8H6O3 |
|
3-羟基异烟酸 | 3-hydroxyisonicotinic acid | 10128-71-9 | C6H5NO3 |
|
3-羟基异烟酰胺 | 3-hydroxyisonicotinamide | 10128-73-1 | C6H6N2O2 |
|
3-羟基异烟腈 | 3-hydroxyisonicotinonitrile | 87032-82-4 | C6H4N2O |
|
3-羟基异恶唑-5-甲酸甲酯 | methyl 3-hydroxy-5-isoxazolecarboxylate | 10068-07-2 | C5H5NO4 |
|
3-羟基异喹啉 | 3-isoquinolinol | 7651-81-2 | C9H7NO |
|
3-羟基头孢 | 3-hydroxy cephalosporin | 54639-48-4 | C28H24N2O5S |
|
3-羟基四氢吡喃 | Oxan-3-ol | 19752-84-2 | C5H10O2 |
|
3-羟基四氢-吡啶甲酸苄酯 | benzyl 3-hydroxypiperidine-1-carboxylate | 95798-22-4 | C13H17NO3 |
|
3-羟基噻吩-2-羧酸乙酯 | ethyl 3-hydroxythiophene-2-carboxylate | 2158-88-5 | C7H8O3S |
|
3-羟基噻吩-2-甲酸 | 3-hydroxythiophene-2-carboxylic acid | 5118-07-0 | C5H4O3S |
|
3-羟基喹啉-4-甲酸 | 3-hydroxyquinoline-4-carboxylic acid | 118-13-8 | C10H7NO3 |
|
3-羟基喹啉-2-酮 | 3-hydroxyquinolin-2(1H)-one | 26386-86-7 | C9H7NO2 |
|
3-羟基喹啉-2-羧酸 | 3-hydroxyquinaldic acid | 15462-45-0 | C10H7NO3 |
|
3-羟基喹啉 | 3-hydroxyquinoline | 580-18-7 | C9H7NO |
|
3-羟基哒嗪-4-羧酸乙酯 | ethyl 2,3-dihydro-3-oxopyridazine-4-carboxylate | 1445-55-2 | C7H8N2O3 |
|
3-羟基呋喃并[2,3-c]吡啶-2-羧酸乙酯 | ethyl 3-hydroxyfuro[2,3-c]pyridine-2-carboxylate | 106531-50-4 | C10H9NO4 |
|
3-羟基呋喃并[2,3-b]吡啶-2-羧酸乙酯 | ethyl 3-hydroxyfuro[2,3-b]pyridine-2-carboxylate | 109274-83-1 | C10H9NO4 |
|
3-羟基吡嗪-2-酰胺 | 3-hydroxypyrazine-2-carboxamide | 55321-99-8 | C5H5N3O2 |
|
3-羟基吡啶钠盐 | 3-Hydoxypyridine sodium salt | 52536-09-1 | C5H5NNaO |
|
3-羟基吡啶酰胺 | 3-hydroxypyridine-2-carboxamide | 933-90-4 | C6H6N2O2 |
|
3-羟基吡啶-N-氧化物 | 3-hydroxypyridine N-oxide | 6602-28-4 | C5H5NO2 |
|
3-羟基吡啶-4-醛 | 3-hydroxypyridine-4-carboxaldehyde | 1849-54-3 | C6H5NO2 |
|
3-羟基吡啶-4-羧酸乙酯 | ethyl 3-hydroxyisonicotinate | 18342-97-7 | C8H9NO3 |
|